Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Cantor Fitzgerald 

Abeona Therapeutics Inc. diskutieren

Abeona Therapeutics Inc.

WKN: A3DMHM / Symbol: ABEO / Name: Abeona Therapeutics / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

4,16 €
5,53 %

Einschätzung Buy
Rendite (%) 14,22 %
Kursziel 35,10
Veränderung
Endet am 24.08.24

Abeona Therapeutics Inc (NASDAQ: ABEO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $38.00 price target on the stock.
Ratings data for ABEO provided by MarketBeat

Abeona Therapeutics Inc (NASDAQ: ABEO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for ABEO provided by MarketBeat

Einschätzung Buy
Rendite (%) 13,04 %
Kursziel 33,73
Veränderung
Endet am 23.04.25

Abeona Therapeutics Inc (NASDAQ: ABEO) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $36.00 price target on the stock.
Ratings data for ABEO provided by MarketBeat

Einschätzung Buy
Rendite (%) 0,48 %
Kursziel 19,31
Veränderung
Endet am 16.05.25

Abeona Therapeutics Inc (NASDAQ: ABEO) had its price target lowered by analysts at Cantor Fitzgerald from $28.00 to $21.00. They now have an "overweight" rating on the stock.
Ratings data for ABEO provided by MarketBeat